NCT05750758View on ClinicalTrials.gov

Rivaroxaban Combined With DAPT Versus DAPT Alone After Drug-coated Balloon Angioplasty

NACompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

February 20, 2023

Primary Completion Date

August 10, 2023

Study Completion Date

December 1, 2023

Conditions

Acute Coronary Syndrome

Interventions

DRUG

rivaroxaban

rivaroxaban 2.5mg bid for 1m

Trial Locations (1)

Unknown

Fuwai central China cardiovascular Hospital, Zhengzhou

All Listed Sponsors

lead

Henan Institute of Cardiovascular Epidemiology

OTHER